SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 123.23 |
| Enterprise Value ($M) | 31.94 |
| Book Value ($M) | 139.56 |
| Book Value / Share | 21.69 |
| Price / Book | 0.88 |
| NCAV ($M) | 95.67 |
| NCAV / Share | 14.87 |
| Price / NCAV | 1.29 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.88 |
| Return on Assets (ROA) | -0.96 |
| Return on Equity (ROE) | -1.20 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.04 |
| Current Ratio | 6.50 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 119.00 |
| Assets | 162.89 |
| Liabilities | 23.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 10.09 |
| Operating Income | -77.74 |
| Net Income | -130.04 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -60.92 |
| Cash from Investing | -0.12 |
| Cash from Financing | 134.87 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | L1 Capital Global Opportunities Master Fund, Ltd. | 0.00 | -100.00 | |
| 13G/A | Armistice Capital, Llc | 0.83 | -60.21 | |
| 13G/A | Empery Asset Management, LP | 1.34 | -24.80 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 112,914 | 346,712 | 32.57 | |
| 152,958 | 442,057 | 34.60 | |
| 118,842 | 414,594 | 28.66 | |
| 81,666 | 261,626 | 31.21 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TIL – Instil Bio, Inc. | TLSA – Tiziana Life Sciences Ltd |
| TNFA – TNF Pharmaceuticals, Inc. | TPST – Tempest Therapeutics, Inc. |
| TRAW – Traws Pharma, Inc. |
Financial data and stock pages provided by
Fintel.io